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EDITORIAL
Multidisciplinary interventions in heart failure
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A National Service Framework for heart failure is urgently
needed
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D
octors working in the field of chronic heart
failure are, in many ways, in an enviable
position. They have a range of effective
treatments that can approximately double life
expectancy for patients with significant left
ventricular systolic dysfunction1 and can drama-
tically reduce the need for repeated hospitalisa-
tions. Their decisions on treatment are based on
a wealth of evidence from carefully conducted
multicentre trials, and they can be in no doubt of
their potential worth to their patients. In their
practice, they are supported by a profusion of
available guidelines produced by experts who
have carefully sifted the evidence. Technological
advances, such as biventricular pacing and
implantable defibrillators, expand the range of
treatment options.
Despite this, the evidence suggests that the
research effort has not resulted in universal
uptake of adequate investigations and treatment
and management of heart failure patients. The
Euroheart survey2 gives a snapshot for consider-
ing the current state of practice. In a pan-
European study of over 11 000 patients admitted
acutely to hospital with heart failure, only two
thirds had ever had an echocardiogram. An
angiotensin converting enzyme (ACE) inhibitor
was prescribed to 62% of patients and a b blocker
to just 37%. Only 17% were on the combination
of diuretic, ACE inhibitor, and b blocker.
This state of affairs matters greatly to the
individual patient, whose life chances are being
reduced, but also to society more broadly. Heart
failure is an enormous consumer of health care
resources. The largest proportion of those costs is
on inpatient hospital care, and heart failure
patients have an extremely high re-admission
rate.
DELIVERY OF CARE
The contrast between what we know is achiev-
able and what we know is happening suggests a
systemic problem with the delivery of care to
heart failure patients. Despite the difficulty in
supporting trials of non-pharmacological man-
agement approaches, the report in this issue by
Holland and colleagues3 shows that there is a
way forward. Structured management pro-
grammes that include patient and carer educa-
tion, the ready availability of advice and support,
and, in particular, some home visits, improve the
life expectancy of patients and reduce their need
for repeated hospitalisations.
Present models of healthcare delivery are
mainly reactive and focused on the relation
between patient and doctor. The patient per-
ceives a problem, and makes an appointment to
see the doctor. Medicine is then done to the
patient in the hospital or surgery. The challenge
posed by the results of analyses like Holland’s is
that we need to re-think this model, at least for
heart failure care. Reaction is not the right
approach: patients need to be able to become
active partners in their management, and the
management strategy needs to be structured to
provide continuing care and support.
Changing the model is of particular impor-
tance for people with chronic disease. Chronic
heart failure is a systemic disease caused by
cardiac dysfunction and it is complex to manage
both cross sectionally (patients may have anae-
mia, renal dysfunction, cardiac dyssynchrony,
myocardial hibernation, associated valve disease,
cardiac arrhythmia, and diabetes to mention but
a few) and longitudinally (the disease is not
static and tends to evolve and therefore requires
regular expert review).
The role of nurses as practitioners in their own
right, and the role of pharmacists and phy-
siotherapists have to be recognised. There is
some formal recognition of the possible worth of
‘‘heart failure nurses’’ with enthusiastic devel-
opment of their roles in some areas. Uptake is,
however, patchy, and depends in large part on
the enthusiasm of a heart failure specialist in a
local hospital. In many parts of the UK there are
simply not enough cardiologists to serve the
population, and certainly no heart failure cardi-
ologist to support a demanding new role.
NATIONAL SERVICE FRAMEWORK
Government initiatives, such as the National
Service Frameworks (NSFs) and guidance from
the National Institute for Clinical Excellence,
have proved the engine for forcing through
improvements in care for patients with coronary
heart disease. These developments are admirable,
but can have their downsides. The deliverers of
health care have to ‘‘deliver targets’’ chosen
centrally (often chosen because they are, at least,
countable). Things not included in a framework
document become lower priorities and can be
sacrificed to some degree to meet the targets.
Heart failure, of course, was not a central feature
of the NSF for coronary artery disease. It appears
as chapter 6, and does contain milestones for
primary care and targets for secondary care. By
April 2002, ‘‘clinical audit data no more than 12
months old that describe the delivery of the key
investigations and treatments’’ should be avail-
able. The stated NSF goal is that ‘‘every hospital
should: offer complete and correct packages of
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audited effective interventions to all people discharged with a
diagnosis of heart failure, demonstrated by clinical audit data
no more than 12 months old.’’ It is difficult to think of many
cardiac networks where these aspirations have been realised.
Management structures seem to be able to put heart failure
to one side.
Heart failure care remains a Cinderella of cardiology.
Although the advent of device therapy has given a veneer of
glamour to proceedings, there is often no systematic
approach to overall management. It can be a matter of
chance who is referred for device therapy, and once the
device is implanted, there is, in many places, no heart
failure cardiologist available to take on continuing care.
Devices can have a striking beneficial effect for some
patients, but their overall impact is small in comparison to
the potential effect of adequate delivery of medication. Device
therapy disproportionately engages administrators and
guideline producers.
We should be engaging with the failure to provide much
more straightforward care. What is needed is recognition by
central government that heart failure is common and
expensive but treatable. A National Service Framework for
heart failure with specific targets is a priority. To whet a
politician’s appetite, we can even say with some certainty
that it might save money.
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Spontaneous triple vessel coronary artery dissection in a patient with effort angina
S
pontaneous coronary artery dissection
(SCAD) is a rare but often fatal cause of
ischaemic heart disease occurring pre-
dominantly in young or middle aged, other-
wise healthy subjects. Although about 250
cases of SCAD have been reported in the
literature, to the best of our knowledge,
spontaneous three vessel coronary dissection
associated with typical effort angina has
never been reported. This case illustrates
coronary angiography and intravascular
ultrasound images in a patient with SCAD
involving all three vessels and treated by
stenting.
A 57 year old man presented with exer-
tional chest pain. His risk factors included
smoking, hypertension, and hyperlipidae-
mia. ECG showed an abnormal Q wave in
lead III and 1 mm ST depression in III, aVF.
Technetium-99m sestamibi SPECT image
showed a moderate fixed defect in the
inferior wall and a reversible defect in the
anterior wall. Selective coronary angiography
revealed SCAD involving all three vessels.
Right coronary angiogram showed linear
dissection starting from the ostium asso-
ciated with distal total occlusion (panel A).
Intravascular ultrasound (IVUS) revealed
prominent dissection flap with false lumen
(*) (panel B). After successful angioplasty
and stenting, no visible dissection flaps with
full recovery of true lumen were seen (panel
C). SCAD at left anterior descending artery
(panels D–F) and left circumflex coronary
artery (panels G–I) were also successfully
treated by stenting after assessment with
IVUS. Five days after intervention, the
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